67 related articles for article (PubMed ID: 9020034)
1. PPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse.
Motojima K; Peters JM; Gonzalez FJ
Biochem Biophys Res Commun; 1997 Jan; 230(1):155-8. PubMed ID: 9020034
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator activated receptor-alpha expression in human liver.
Palmer CN; Hsu MH; Griffin KJ; Raucy JL; Johnson EF
Mol Pharmacol; 1998 Jan; 53(1):14-22. PubMed ID: 9443928
[TBL] [Abstract][Full Text] [Related]
4. Influence of peroxisome proliferator-activated receptor alpha on ubiquinone biosynthesis.
Turunen M; Peters JM; Gonzalez FJ; Schedin S; Dallner G
J Mol Biol; 2000 Mar; 297(3):607-14. PubMed ID: 10731415
[TBL] [Abstract][Full Text] [Related]
5. Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha.
Peters JM; Taubeneck MW; Keen CL; Gonzalez FJ
Teratology; 1997 Nov; 56(5):311-6. PubMed ID: 9451755
[TBL] [Abstract][Full Text] [Related]
6. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
7. An upstream region of the enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase gene directs luciferase expression in liver in response to peroxisome proliferators in transgenic mice.
Alvares K; Fan C; Dadras SS; Yeldandi AV; Rachubinski RA; Capone JP; Subramani S; Iannaccone PM; Rao MS; Reddy JK
Cancer Res; 1994 May; 54(9):2303-6. PubMed ID: 8162569
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges.
Cui X; Kawashima H; Barclay TB; Peters JM; Gonzalez FJ; Morgan ET; Strobel HW
J Pharmacol Exp Ther; 2001 Feb; 296(2):542-50. PubMed ID: 11160642
[TBL] [Abstract][Full Text] [Related]
9. Reduction of all-trans-retinal in the mouse liver peroxisome fraction by the short-chain dehydrogenase/reductase RRD: induction by the PPAR alpha ligand clofibrate.
Lei Z; Chen W; Zhang M; Napoli JL
Biochemistry; 2003 Apr; 42(14):4190-6. PubMed ID: 12680773
[TBL] [Abstract][Full Text] [Related]
10. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
Fu J; Gaetani S; Oveisi F; Lo Verme J; Serrano A; Rodríguez De Fonseca F; Rosengarth A; Luecke H; Di Giacomo B; Tarzia G; Piomelli D
Nature; 2003 Sep; 425(6953):90-3. PubMed ID: 12955147
[TBL] [Abstract][Full Text] [Related]
11. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
[TBL] [Abstract][Full Text] [Related]
12. Delineating peroxisome proliferator action to improve human risk assessment.
Green S; Issemann I; Tugwood JD; Prince RA; Aldridge TC
Prog Clin Biol Res; 1994; 387():311-33. PubMed ID: 7972256
[No Abstract] [Full Text] [Related]
13. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.
Motojima K; Passilly P; Peters JM; Gonzalez FJ; Latruffe N
J Biol Chem; 1998 Jul; 273(27):16710-4. PubMed ID: 9642225
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.
Lee SS; Pineau T; Drago J; Lee EJ; Owens JW; Kroetz DL; Fernandez-Salguero PM; Westphal H; Gonzalez FJ
Mol Cell Biol; 1995 Jun; 15(6):3012-22. PubMed ID: 7539101
[TBL] [Abstract][Full Text] [Related]
15. Specific repression of transthyretin gene expression in rat liver by a peroxisome proliferator clofibrate.
Motojima K; Goto S; Imanaka T
Biochem Biophys Res Commun; 1992 Oct; 188(2):799-806. PubMed ID: 1280124
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR)-dependent and -independent transcriptional modulation of several non-peroxisomal genes by peroxisome proliferators.
Motojima K
Biochimie; 1997; 79(2-3):101-6. PubMed ID: 9209703
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the peroxisome proliferator-activated receptor alpha gene, PPAR alpha.
Lee SS; Gonzalez FJ
Ann N Y Acad Sci; 1996 Dec; 804():524-9. PubMed ID: 8993570
[No Abstract] [Full Text] [Related]
18. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.
Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR
Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884
[TBL] [Abstract][Full Text] [Related]
19. Effect of peroxisome proliferating hypolipidemic agents on serum activity levels of arylesterase and cholinesterase in rats and mice.
Butler EG; England PJ; Williams GM
Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):125-8. PubMed ID: 3381006
[TBL] [Abstract][Full Text] [Related]
20. Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero.
Schmuth M; Schoonjans K; Yu QC; Fluhr JW; Crumrine D; Hachem JP; Lau P; Auwerx J; Elias PM; Feingold KR
J Invest Dermatol; 2002 Dec; 119(6):1298-303. PubMed ID: 12485431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
